The recent success of intratumorally-injected adeno-encoded, radiation-inducible-promoter driven hTNF-α, AdEgr.TNF.11D (TNFerade)+gemcitabine [12] proves TNF-α could still be useful as anti-tumor agent. This evidence concerns the gene TNF and neoplasm.